Skip to main content

and
  1. Article

    Open Access

    Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma

    Originally described as interpatient variability, tumour heterogeneity has now been demonstrated to occur intrapatiently, within the same lesion, or in different lesions of the same patient. Tumour heterogenei...

    Luigi Fattore, Ciro Francesco Ruggiero, Domenico Liguoro in Cell Death & Disease (2019)

  2. Article

    Open Access

    Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

    Drug resistance imposes severe limitations to the efficacy of targeted therapy in BRAF-mutated metastatic melanoma. Although this issue has been mitigated by the development of combination therapies with BRAF ...

    Luigi Fattore, Ciro Francesco Ruggiero, Maria Elena Pisanu in Cell Death & Differentiation (2019)

  3. Article

    Open Access

    Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

    David Carbone, Michael Sharpnack, Kai He in Journal of Translational Medicine (2018)

  4. Article

    Open Access

    Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

    Vera Hirsh, Sandro Pignata, Melissa Bersanelli in Journal of Translational Medicine (2017)